Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/BBM stock hub

CSE/BBM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/BBMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/BBM

In the news

Latest news · CSE/BBM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-288.2

P25 -121.5P50 -40.9P75 0.5

ROIC-146.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/BBM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

CAD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 4.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA09609Y1016
Last refreshed	2026-05-10
Market cap	CAD 5M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/BBM
Website	https://blueberriesmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.65%
EV Earnings	-2.96x
EV/Sales	15.79x
P/B ratio	15.42x
P/S ratio	15.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	47.34%
Gross Profit	CAD 147,824
Gross Profit Growth	-10.15%
Gross Profit Growth Q	-6.1%
Gross Profit Growth5 Y	18.83%
Net Income	CAD -1.7M
Net Income Growth Years	0%
Pretax Margin	-533.44%
ROA	-83.67
Roa5y	-38.73
ROCE	-429.4
ROE	-288.2
Roe5y	-152.2
ROIC	-146.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	100.1%
Cagr3y	-26.31%
Cagr5y	-37.52%
EPS Growth Years	0
Revenue Growth	-33.76x
Revenue Growth Q	-38.33x
Revenue Growth Years	0x
Revenue Growth3 Y	9.87x
Revenue Growth5 Y	36.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.3
Assets	CAD 679,623
Cash	CAD 26,393
Current Assets	CAD 341,637
Current Liabilities	CAD 358,452
Debt	CAD 7,185
Debt Equity	CAD 0.02
Equity	CAD 321,171
Liabilities	CAD 358,452
Long Term Assets	CAD 337,986
Long Term Liabilities	CAD 0
Net Cash	CAD 19,208
Net Cash By Market Cap	CAD 0.39
Net Cash Growth	-64.84%
Net Debt Equity	CAD -0.06
Tangible Book Value	CAD 321,170
Tangible Book Value Per Share	CAD 0
WACC	18.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.95
Inventory Turnover	1.21
Net Working Capital	CAD -36,023
Quick ratio	0.86
Working Capital	CAD -16,815

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100%
200-day SMA	0.01
3Y total return	-60%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.48%
All Time High	0.88
All Time High Change	-98.86%
All Time High Date	2019-03-21
All Time Low	0.01
All Time Low Change	100%
All Time Low Date	2023-11-30
ATR	0
Beta	2.58
Beta1y	-4.83
Beta2y	-3.37
High	0.01
High52	0.03
High52 Date	2025-08-14
High52ch	-60%
Low	0.01
Low52	0.01
Low52 Date	2025-05-27
Low52ch	100%
Ma50ch	-33.33%
Price vs 200-day SMA	-28.57%
RSI	44.76
RSI Monthly	43.19
RSI Weekly	45.08
Sharpe ratio	2.1x
Sortino ratio	4.3
Total Return	-18.53%
Tr1m	-33.33%
Tr3m	-33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.4M
Operating margin	-441.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	150,558,567%
Net Borrowing	-1,903
Shares Insiders	16.61%
Shares Out	495,090,087
Shares Qo Q	9.15%
Shares Yo Y	18.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	33,342.1x
Bv Per Share	0
Ch1m	-33.33
Ch1y	100
Ch3m	-33.33
Ch3y	-60
Ch5y	-90.48
Ch6m	-33.33
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	98,325
Dollar Volume	157.9
Earnings Date	2026-05-28
EBIT	CAD -1.4M
EBITDA	CAD -1.3M
EPS	CAD -0
F Score	2
Financing CF	1,181,551
Fiscal Year End	December
Is Primary Listing	1
Last Earnings Date	2025-11-24
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-25.37%
Ma20	0.01
Ma20ch	-31.03%
Net CF	-39,688
Next Earnings Date	2026-05-28
Open	0.01
Ppne	13,071
Price Date	2026-05-08
Ptbv Ratio	15.42
Relative Volume	0.47x
Revenue	312,285x
SBC By Revenue	5.67x
Share Based Comp	17,722
Tr6m	-33.33%
Volume	15,794

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/BBM pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/BBM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/BBM?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+16.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+18.5%

Negative means the company is buying back shares.

Technical

CSE/BBM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

-28.6%

50/200-day relationship not available

Beta (5Y)

2.58

More volatile than the market

Sharpe ratio

2.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/BBM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/BBM stock rating?

cse/BBM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/BBM analysis?

The full report lives at /stocks/cse/BBM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/BBM?

The latest report frames cse/BBM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/BBM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.